Working… Menu

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer (ACTICCA-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02170090
Recruitment Status : Recruiting
First Posted : June 23, 2014
Last Update Posted : October 5, 2021
Deutsche Krebshilfe e.V., Bonn (Germany)
Cancer Research UK
Australasian Gastro-Intestinal Trials Group
Dutch Cancer Society
Information provided by (Responsible Party):
Universitätsklinikum Hamburg-Eppendorf